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Abstract 
Continuous infusions of intravenous anesthetics 
are becoming increasingly popular during surgi- 
cal procedures, largely because relatively precise, 
consistent control of anesthetic depth is possible 
End points 
over intravenous injection techniques. Iithis pa- 
per we investigate the main issues involved with 
the development of automatic intravenous anes- 
thesia delivery systems in the context of robust 
multivariable control. We present a pharmacody- 
namic model that may be suitable for closed-loop 
control, and discuss clinical data collected from 
human subjects during actual surgical conditions 
with the anesthetic propofol. 
1. Introduction 
This paper considers automatic control of anes- 
thetic depth during surgery with a view to applying 
multivariable control methods. A preliminary in- 
vestigation is conducted into modeling and control 
for automated anesthesia delivery, which includes 
analysis of clinical data collected during surgery. 
Continuous infusions, delivered by digitally pro- 
grammed pumps, are a commonly used approach 
for delivering intravenous anesthetic during surgi- 
cal procedures. They allow the physician to pre- 
cisely set the flow rate of anesthetic into the pa- 
tient in an attempt to maintain appropriate levels 
of anesthetic depth. This method of administering 
drug has largely replaced the previous approach in 
which, instead, a series of periodic injections are 
given. The advantage of the infusion method is 
that the drug level in the body can be kept more 
constant, in contrast to the sequence of peaks and 
valleys that result from periodic injections - thus 
less drug is needed, increasing patient safety. 
Although such infusion systems enable physicians 
to continuously adjust the rate of anesthetic up- 
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Figure 1: Anesthetic Model 
take, it has been suggested in the medical liter- 
ature [4][7][9] that this task could be more accu- 
rately performed by an automatic feedback con- 
trol device. Firstly, because during routine surgi- 
cal situations automatic control of the anesthetic 
delivery would free the clinician to focus on more 
important issues. Secondly, because a control sys- 
tem can continuously monitor and make fine ad- 
justments, so that the minimum amount of drug 
required to achieve a desired effect is used. 
We hope that the issues raised in this paper will 
provide the basis for a program of successful de- 
velopment of automated intravenous anesthesia 
delivery. 
2. Anesthesia Background 
The main objective of anesthesia during surgery 
is to ensure that the patient is sufficiently insensi- 
tive to painful stimuli. At the same time, it is im- 
portant for safety reasons, that the patient not be 
overly anesthetized. Unfortunately, so far, physi- 
cians do not have a direct and reliable method to 
measure the degree of patient mental awareness 
or anesthetic depth. In particular, and contrary to 
popular intuition, EEG signals alone do not provide 
an accurate indication of anesthetic depth. 
The approach that is adopted for estimating the 
ill-defined quantity anesthetic depth is to focus on 
physical processes that are directly regulated by 
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Figure 2: Pharmacodynamic Model 
the brain. Physicians controlling anesthetic depth 
take an input-output view of the patient as shown 
in Figure 1. The inputs to the patient are the phys- 
ical stimuli and the dose of anesthetic. The out- 
puts, or end points, are measurements such as ar- 
terial blood pressure (AP), heart rate (HR), cardiac 
output (CO) and pulmonary arterial pressure (PAP). 
The key property of each of these end points is that 
they are controlled by the brain. Thus their levels, 
to some degree, reflect the perception of painful 
stimuli. During surgery, if these endpoints react 
significantly to the stimuli that are applied to the 
patient, such as an incision to the skin, it is con- 
cluded that the anesthetic depth is insufficient and 
more anesthetic is required. 
Maintaining a particular anesthetic depth, in the 
absence of stimuli, therefore translates into keep- 
ing these endpoints at a constant level, which is 
the goal of an automatic control system for con- 
trol of intravenous anesthesia. Thus, a model is 
required that relates the endpoints to the time- 
history of the anesthetic input - namely a phar- 
macodynamic model. 
3. Pharmacodynamic Modeling 
Pharmacodynamic models have long been of inter- 
est in medicine and pharmacology. Despite this 
history, there are few models that enjoy substan- 
tial predictive success [3]. This is due in part to the 
range of variation between human subjects, but is 
largely because the precise mechanisms by which 
most anesthetic drugs operate are not well under- 
stood. 
Fortunately, we seek a model for the purposes of 
closed-loop, or feedback, control. Thus a simple 
model that captures the salient dynamical features 
of the pharmacodynamic process is both sufficient 
and preferred. The structure of the model we pro- 
pose is shown in Figure 2. Models of a similar 
form appear in various versions in the literature 
(see bibliographic references), and we believe the 
one presented here may be particularly suitable for 
control. 
The model consists of three dynamical compo- 
nents: the first is the plasma into which the drug 
infusion flows; the plasma interacts with the brain 
through the blood brain barrier so that part of 
the drug entering the plasma eventually enters the 
brain; the brain sets the end point, which depends 
on the drug concentration in the brain. 
The models we choose for the plasma and brain 
concentrations, yp and yb respectively, ignoring 
for now their interaction, are linear time-invariant 
systems corresponding to the transfer functions 
A B C 
s + u  s + b  s + c  T p ( s )  := -+ -+ -
where all the parameters are real and positive. 
These transfer functions can be associated with 
the standard three- and one- compartment mod- 
els (see e.g., [3][4]). 
The interaction between the brain and plasma 
components of the model are described by the lin- 
ear gradient equation 
(1) 
where E is a non-zero parameter. This equation 
can be interpreted as flow through a membrane. 
Hence, the map from the infusion w to yb can be 
described by a stable transfer function of the form 
flow(t) = E(Yp(t) - Yb(t) ) 
(2) 
u2s2 + als  + uo 
T ( s )  = 
S* + b3~3 + b2~2 + bls + bo' 
The final component of the model is comprised 
of a time delay and a static nonlinearity. Given a 
parametrized family of functions, 7, from which 
the nonlinearity is chosen, the map from yb to the 
endpoint z is defined by 
z ( t )  = F(yb(t - t o )  ) 
where F E and to > 0. This is the least physi- 
cally motivated of the components. The simplest 
relevant choice for the family 7 is the set of one- 
parameter affine functions; in [8][3] a set of sig- 
moidal curves is chosen. The time delay is also 
a n  empirically determined part of the model, and 
is clearly necessary as we see in the next section. 
Some have suggested that this delay is due to re- 
circulation time ([5]) in the plasma, but this is not 
conclusive. 
The parameters in (2) and the chosen set are 
expected to vary significantly among individual 
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subjects as is commonly observed in pharmacody- 
namic and pharmacokinetic models; thus the use 
of the above model for feedback control may re- 
quire customized fitting. An important feature of 
( Z ) ,  that does not seem to be widely appreciated, 
is that the transfer function has relative degree of 
at least two. In, e.g. [5][8], this is not the case: 
namely the model predicts a discontinuous jump 
in the end point when an injection is made; a situ- 
ation that is seldom observed. 
4. Clinical Data 
This section presents data collected from three hu- 
man subjects during surgery. We will not evaluate 
the model of the previous section here, as our data 
set is small and the sources of stimuli significant; 
a detailed evaluation will be reported elsewhere. 
The data is used to illustrate some of the inherent 
difficulties associated with control of anesthetic 
depth. The subjects studied were patients about to 
undergo liver transplant surgery at UCLA Medical 
Center the specific anesthetic used was propofol. 
The advantage in studying these patients is that a 
larger number of end points are available than in 
more minor surgical procedures. Of course a par- 
tial disadvantage is the (hemodynamic) responses 
observed may not be strongly representative of 
those usually observed in healthier subjects. 
The endpoints we were able to measure are those 
listed in Figure 1. Here we do not include cardiac 
output since it is measured infrequently. The data 
was collected during the one hour period prior to 
the main (abdominal) incision. The plots of the 
(systemic) arterial pressures have two traces: sys- 
tolic and diastolic pressures. When the patients 
were first anesthetized these pressures were mea- 
sured using a noninvasive cuff around the patients 
arm, which produced readings at periodic inter- 
vals. Later a catheter was inserted into a radial 
artery which provided continuous measurement of 
arterial pressure. Thus the transition from sam- 
pled to continuous pressure readings in Figures 7 
and 9. The data in all the plots (except the sam- 
pled cuff measurements) are low-pass filtered to 
smooth quantization error. The time profiles of 
the amounts of drug administered to the three pa- 
tients are shown in Table l; the table provides the 
amount of propofol given by injection (bolus), and 
the programmed setting changes to the continu- 
ous infusion pump. 
'after approval from the UCLA Human Subjects Pro- 
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Table 1: Propofol Time-histories 
Patient A had arterial and pulmonary arterial lines 
in place before the start of anesthesia; these were 
used previously for monitoring the patient in the 
intensive care unit. He had a tube in his trachea 
and was mechanically ventilated. Figure 3 shows 
the heart rate of the patient from the time that 
anesthetic was first given. This response was atyp- 
ical, since the heart rate increased (tachycardia) 
after propofol was administered, whereas a char- 
acteristic response is a decrease. This was inter- 
preted as a reflex response, by the heart, due to the 
patient having low blood volume: propofol causes 
blood vessels to dilate, and therefore, if intravas- 
cular volume is low, the heart senses less blood re- 
turn and responds by increasing its rate. Figure 4 
plots the measured arterial pressures (systolic and 
diastolic) and is qualitatively typical; that is, the 
pressures decrease with administration of anes- 
thetic. However, the response is unusually small. 
Figure 3: Patient A: Heart Rate 
Pulmonary arterial pressures are shown in Fig- 
ure 5: these pressures are initially higher than 
usual because the patient was awake and on a ven- 
tilator (which is very painful). These pressures 
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Figure 5: Patient A: Pulmonary Arterial Pressures 
decreased characteristically in response to the 
propofol, indicating increasing anesthetic depth, 
but settled at values considered to be low. These 
low values were again believed to be due to the 
afore-mentioned low blood volume of Patient A. 
Patient A, though having some atypical responses, 
provides illuminating reference data because no 
significant stimuli were applied during the 45 
minute period recorded; this was not true in the 
other two subjects where many painful stimuli 
were applied. Because of the absence of pain it is 
possible to fit, using the pharmacodynamic model 
of Section 3, the data of Figures 4 and 5; to get close 
fits it is sufficient to choose the set to be the 
one-parameter family of affine functions. In par- 
ticular this data demonstrates a time delay: From 
Table A, a bolus (injection) was given at time 0:OO 
min and we see a response after approximately 4 
minutes; similarly a bolus was given at 13:OO rnin 
and again a response occurs after 4 minutes. The 
dip in the graph at 6:OO min is due to a (large) fen- 
tanyl bolus that was administered; fentanyl is an- 
other anesthetic used to supplement the propofol 
anesthetic. 
A further feature of the data obtained from Pa- 
tient A is that since pulmonary arterial line was 
initially present, we were able to obtain measure- 
ments of the pulmonary arterial pressures from 
the onset of anesthesia. In Patients B 
data was not available until after 40 minu 
the pulmonary arterial line was in place, at which 
time a steady state response to the propofol had 
already been reached. 
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Figure 7: Patient B: Arterial Pressures 
Patients B and C have more typical responses to the 
propofol, and illustrate many of the common stim- 
ulating events in surgery. The 
shown in Figures 6 and 8. At 
tients had yet to receive anesthetic. Once propofol 
was given there is a resulting small decrease in the 
heart rate. Before the heart rate decreases si@- 
candy there is a large increase, at 3 min and 8 min 
for Patients B and C respectively. This was caused 
by the painful stimulus of intubation; that is a tube 
was inserted into the trachea to effect mechanical 
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ventilation. Once this procedure was complete the 
heart rates fell rapidly to approximately 20 per- 
cent below their initial values. The next significant 
event on the traces was caused by needle sticks, 
and larger catheter placements in the neck, associ- 
ated with the pulmonary arterial line. This began 
at 35 min in Patient B and 22 min in Patient C, and 
produces a number of spikes as the line is guided 
into the pulmonary artery. The steep drop-off at 
40 min in Figure 8 is the reaction to an injection of 
fentanyl. 
Figure 8: Patient C: Heart Rate 
Figure 9 Patient C: Arterial Pressures 
The arterial plots in Figures 7 and 9 exhibit simi- 
lar responses to the anesthetic and stimuli as the 
heart rate plots: an increase of propofol reduces 
the arterial pressures and painful stimuli raises 
them. 
5. Conclusions 
In this paper we have identified the main areas 
that need to be more thoroughly researched in 
order to develop an automated intravenous anes- 
thesia delivery system. After describing the basic 
features of clinical anesthesiology we presented 
a general pharmacodynamic model and (hemody- 
namic) data collected during surgery with the anes- 
thetic propofol. A main objective in presenting 
the obtained data was to highlight the phenomena 
with which an automated delivery system will have 
to contend: large modeling uncertainties (incon- 
sistent stimuli and patient response, unknown bi- 
ological mechanisms), nonlinear patient response 
and poorly defined performance objectives. 
We are currently examining the next stage of this 
research program which involves a more in depth 
study of the pharmacodynamic model, and the de- 
velopment of compatible models of stimuli. In par- 
ticular the predictive abilities of these models are 
to be investigated. 
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